Castle Biosciences (CSTL) Other Non Operating Income (2018 - 2026)
Castle Biosciences' (CSTL) quarterly Other Non Operating Income came in at -$439000.0 in Q1 2026, down 557.29% quarter-over-quarter from $96000.0 in Q4 2025.
Castle Biosciences (CSTL) Other Non Operating Income (2018 - 2026) Analysis & Trends
Castle Biosciences has disclosed Other Non Operating Income across 5 years of filings, most recently posting -$439000.0 for Q1 2026.
- Other Non Operating Income for Q1 2026 came in at -$439000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$295000.0 (up 78.93% YoY), and the FY2025 annual result was $144000.0, changed N/A from the prior year.
- Other Non Operating Income came in at -$439000.0 for Q1 2026 at Castle Biosciences, down from $96000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $96000.0 in Q4 2025 to a low of -$439000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Castle Biosciences | 629.76 Mn | 368.04 Mn | 63.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -439,000.00 |
| Dec 31, 2025 | 96,000.00 |
| Sep 30, 2025 | 48,000.00 |
| Dec 31, 2020 | -1.40 Mn |
| Dec 31, 2019 | -7.91 Mn |
| Sep 30, 2019 | 5.20 Mn |
| Jun 30, 2019 | -189,000.00 |
| Mar 31, 2019 | -33,000.00 |
| Dec 31, 2018 | -272,000.00 |
| Jun 30, 2018 | 34,038.00 |